The pandemic continues to cause unprecedented disruption across industries worldwide.
Get detailed insights regarding the impact of COVID-19 on the market.
The global intraoperative imaging market reached a value of US$ 2.0 Billion in 2021. Looking forward, IMARC Group expects the market to reach US$ 2.8 Billion by 2027, exhibiting a CAGR of 5.4% during 2022-2027. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.
Intraoperative imaging enables surgeons to get the image of implant position and surgical view of anatomical structures, such as organs, tissues, and cells. It is widely utilized in glioblastoma neurosurgery and to treat dystonia, epilepsy, essential tremor, glioma, and Parkinson's disease. It is also used to perform minimally invasive surgery (MIS) of spines, verifying surgical accuracy and ensuring that a spinal implant is placed in the desired place. Presently, intraoperative three-dimensional (3D) imaging with mobile C-arms is gaining traction for reconstructing complex joint fractures. It shows the position of instruments in real-time, which aid in improving precision and allowing safe implant placement in challenging situations.
A considerable increase in the number of surgeries due to the growing overall and aging population and the rising prevalence of chronic ailments represent one of the main factors driving the market. Moreover, rising awareness about the advantages of MIS as compared to conventional surgeries is escalating the need for intraoperative imaging. It can also be used to perform and confirm correct alignment and orientation of the implant, such as the acetabular cup, and rule out accompanying fractures of the acetabular region or the femoral shaft. Apart from this, several manufacturers are offering state-of-the-art intraoperative imaging systems with augmented reality (AR) to correct brain deformation and for laparoscopic liver surgical navigation. Furthermore, researchers are focusing on innovative strategies and advanced technologies to introduce performant and high-resolution intraoperative imaging to advance novel surgical techniques.
IMARC Group provides an analysis of the key trends in each sub-segment of the global intraoperative imaging market, along with forecasts at the global, regional and country level from 2022-2027. Our report has categorized the market based on product, application and end use.
Breakup by Product:
Breakup by Application:
Breakup by End Use:
Breakup by Region:
The competitive landscape of the industry has also been examined along with the profiles of the key players being Brainlab AG, Canon Inc., General Electric Company, IMRIS (Deerfield Imaging Inc.), Koninklijke Philips N.V., Medtronic plc, NeuroLogica Corp. (Samsung Electronics Co. Ltd.), Shenzhen Anke High-Tech Co. Ltd, Shimadzu Corporation, Siemens Ag, Stryker Corporation and Ziehm Imaging GmbH.
|Base Year of the Analysis||2021|
|Segment Coverage||Product, Application, End Use, Region|
|Region Covered||Asia Pacific, Europe, North America, Latin America, Middle East and Africa|
|Countries Covered||United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico|
|Companies Covered||Brainlab AG, Canon Inc., General Electric Company, IMRIS (Deerfield Imaging Inc.), Koninklijke Philips N.V., Medtronic plc, NeuroLogica Corp. (Samsung Electronics Co. Ltd.), Shenzhen Anke High-Tech Co. Ltd, Shimadzu Corporation, Siemens Ag, Stryker Corporation and Ziehm Imaging GmbH|
|Customization Scope||10% Free Customization|
|Report Price and Purchase Option||Single User License: US$ 2499
Five User License: US$ 3499
Corporate License: US$ 4499
|Post-Sale Analyst Support||10-12 Weeks|
|Delivery Format||PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)|
REACH OUT TO US
Call us on
( US: +1-631-791-1145 )
( UK: +44-753-713-2163 )
( India: +91 120 433 0800 )
Drop us an email at